REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAKR.L Share News (AKR)

  • There is currently no data for AKR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small cap round-up: Matra, Strategic Natural, SWP...

Wed, 17th Mar 2010 12:48

Losses at Matra Petroleum in 2009 reduced to €2.3m from €8.7m. Results of the A-13 well are expected in May and these will help us define the extent of the Sokolovskoe development. Operational difficulties have caused minor increases in the expected well costs from $4.5m to $4.85m, the company remains well funded to complete the well for its operational commitments for 2010. We expect to embark upon the field development during the second half of 2010, Matra added.Online banking systems group Neovia's total revenues declined from $75.9m in 2008 to $64.5m in 2009 with the loss after tax for 2009 $9.8m (2008: $8.1m). "The fourth quarter of 2009 saw stronger performance for both the e-wallet and NETBANX businesses compared to the third quarter, and revenue for the first two months of 2010 was in line with management's expectations," it added.Strategic Natural has conditionally placed 19.2m new shares at 15p, raising about £2.7m. The cash will be used to fund the development and commercialisation of mining assets in the Eastern Cape in South Africa and repay a short term facility incurred to repay a working capital loan to Elitheni Coal. All the directors, who directly and indirectly own 33.2% of the company, took part in the placing.Interim profits soared at mini-conglomerate SWP to £1.2m from £452,000 despite slightly lower turnover of £12.4m. "Notwithstanding the disappointing economic outlook in general the current period has started strongly and together with the results posted for the first half the board is confident that we will deliver very positive results for the financial year to June 2010," it added.Shares in oil and gas firm Aminex jumped after it announced that identified several potential oil and gas bearing intervals in its Olympia Minerals-1 well at Shoats Creek, Louisiana (OM-1).Aminex said the well reached total measured depth of 9,508 feet MD (2,898 metres MD) and that wireline logs have identified several potential oil and gas bearing intervals in Cockfield sands between 8,200 and 9,335 feet. "OM-1 is the first new well to have been drilled by our US subsidiary as operator for several years, encountering the Cockfield sands exactly as anticipated," said chairman Brian Hall.Akers Biosciences has licensed the exclusive sales, marketing, and distribution rights to its BreathScan product line in the UK and Republic of Ireland, to BreathScan International (BIL) for a period of five years.London-based BIL will also have a non-exclusive right to develop opportunities internationally, outside of North America. In return for the licence, Akers Biosciences will receive a 20% stake in BIL. Gold producer Avocet Mining dropped after it swung to a pre-tax loss of $10.56m in the nine month ended 31 December compared with a profit of $31.57m last time.On a pro forma basis, profit before taxation and exceptional items fell to $7.89m from $12.45m previously.
More News
8 Oct 2018 13:10

Akers Biosciences appoints chief executive after settling legal battle

(Sharecast News) - Akers Biosciences appointed Howard Yeaton as chief executive on Monday as the company reached a settlement in its legal dispute with Pulse Health.

Read more
15 Aug 2018 08:04

Akers Biosciences profits hit over antigen difficulties

(Sharecast News) - Akers Biosciences' losses burgeoned as second-quarter revenues were cut in half after softer sales of its flagship Heparin rapid assay products had offset a stronger showing in its breathalyser unit.

Read more
3 Apr 2018 13:45

Akers Biosciences 2017 Revenue Rises But Loss Widens On Higher Costs

LONDON (Alliance News) - Akers Biosciences Inc on Tuesday said revenue grew in 2017, but its loss widened due to increased costs across the business.The AIM-listed firm

Read more
16 Mar 2018 18:11

Akers Biosciences Nets USD49,000 From Warrants Exercise (ALLISS)

LONDON (Alliance News) - Akers Biosciences Inc, a developer of health screening and testing products, said Friday that it has netted USD48,750 from warrants to

Read more
16 Feb 2017 08:44

Akers Biosciences gains US patent for disposable cartridge

(ShareCast News) - Akers Biosciences, a developer of rapid health information technologies, has been granted a US patent for its wellness disposable markers. The US Patent and Trademark Office has given a patent for its proprietary cartridge for the optical scanning device used in the company's Brea

Read more
10 Jan 2017 12:06

Akers Biosciences to raise $2m in US placing

(ShareCast News) - Rapid diagnostic test manufacturer Akers Biosciences said it plans to issue $2m of new shares plus warrants over another $1m worth of shares. The AIM- and Nasdaq-listed outfit said funds will be used for working capital as well as to accelerate growth in the US and in internationa

Read more
19 Dec 2016 14:52

Akers Biosciences signs three year deal with US hospital group

(ShareCast News) - Rapid health information technology developer Akers Biosciences announced on Friday it has signed a three-year agreement with the Greater New York Hospital Association to introduce its flagship rapid tests for heparin-induced thrombocytopenia across the association's network of ov

Read more
12 Dec 2016 16:03

UK Shareholder Meetings Calendar - Next 7 Days

Read more
1 Dec 2016 12:13

Akers Agrees Deal For First Check To Sell Cholesterol Test In US

Read more
10 Nov 2016 09:46

Akers Biosciences gains European patent for ketone breath device

(ShareCast News) - Akers Biosciences, a developer of rapid health information technologies, gains a European patent for its ketone acid breath device. The European Patent Office has issued a patent covering the company's breath ketone detector, a breath device to monitor ketone levels, which follows

Read more
19 Aug 2016 12:18

Akers Biosciences, ChubeWorkx settle lengthy legal dispute

(ShareCast News) - Akers Biosciences has reached a settlement agreement with former distributor ChubeWorkx Guernsey Ltd, allowing it to recover $1.25m in product and cash and end a lengthy legal dispute between the pair. ChubeWorkx would recover what it was owed from a promissory note by taking deli

Read more
18 Aug 2016 07:22

Akers Says Test Results "Highly Successful" For BreathScan OxiChek

Read more
30 Jun 2016 08:56

Akers Says Rapid Chlamydia Test Trial "Highly Successful"

Read more
27 Jun 2016 08:16

Akers Biosciences Signs First Distribution Deal For BreathScan OxiChek

Read more
26 May 2016 16:27

DIRECTOR DEALINGS: Akers Biosciences Chief Executive Buys First Shares

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.